PHILADELPHIA, April 27, 2021 – The American College of Physicians (ACP) today released a new Clinical Guideline regarding the appropriate use of point-of-care ultrasound (POCUS) for patients with acute dyspnea in emergency departments or in-patient settings. The new, evidence-based guideline was published in
Annals of Internal Medicine .
Appropriate Use of Point-of-Care Ultrasound in Patients with Acute Dyspnea in Emergency Department or In-patient Settings: A Clinical Guideline from the American College of Physicians, was developed by ACP to provide clinical recommendations to improve the diagnostic, treatment, and health outcomes of patients with suspected congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax. Acute dyspnea is a common symptom that contributes to more than 1 million emergency room visits each year and is defined as a subjective and distressing experience of breathing discomfort.
The CT Senate should act now to remove non-medical vaccine exemptions.
Last week, the Connecticut House of Representatives advanced legislation to eliminate non-medical exemptions from school-entry immunizations, a timely and important step towards protecting our children and families from vaccine-preventable illnesses. The Senate should move decisively to do the same.
Our professional society, the American College of Physicians (ACP), established national policy in 2015 recommending that vaccine medical exemptions be the only type allowed under state laws. High immunization rates are necessary to safeguard infants and children for whom vaccines may be truly unsafe, such as those with an allergy to a vaccine component or with a primary or acquired immune disorder, for example related to cancer treatment. These children did not choose their illness or condition; sending them to school with voluntarily unvaccinated students risks exposing them to a life-threatening, vaccine-preventab
Apr 27, 2021
Clinical guide green lights point-of-care imaging with standard diagnosis in ED, inpatient settings
Clinicians can use add-on point-of-care ultrasonography in patients with unspecified acute dyspnea in the emergency department (ED) or inpatient setting, according to the American College of Physicians (ACP), although the recommendation is based on a low certainty of evidence.
Combining point-of-care ultrasonography (POCUS) with the standard diagnostic pathway increased the proportion of correct diagnoses by 32%, boosted the sensitivity of standard testing without “a substantial tradeoff in specificity,” did not seem to be tied to any serious harms, is not a high-cost test, and did not result in a longer length of stay (LOS) for patients, wrote Amir Qaseem, MD, PhD, MHA, of the ACP in Philadelphia, and co-authors on the college’s clinical guidelines committee.
Jack Remington, infectious-disease expert and clinician, dies at 90
The Stanford physician devised a test that saved babies’ lives by showing whether they needed immediate treatment for a parasitic disease called toxoplasmosis. Apr 27 2021
Jack Remington
Jack Remington, MD, professor emeritus of infectious diseases at Stanford Medicine, died April 8 in Menlo Park, California, of complications from an injury he sustained in a fall. He was 90.
An extreme-sports enthusiast with a penchant for mountain climbing, which over the years exacted a physical toll on his body, Remington was a hard-charging patient advocate who put his patients’ needs above all else.
He was also an accomplished scientist who conducted groundbreaking research on
Journal of the American College of Cardiology)
Stroke survivors trying to regain arm function in rehabilitation found incremental improvement with vagus nerve stimulation in the VNS-REHAB trial. (
The Lancet)
The American College of Physicians released a guideline on the use of point-of-care ultrasound for patients with acute dyspnea.
A theory posits that dual SGLT1 and SGLT2 inhibition could improve cardiovascular outcomes for people with diabetes. (
Circulation)
Philips Stellarex paclitaxel drug-coated balloon did not increase deaths at 5 years over percutaneous transluminal angioplasty in a 600-patient meta-analysis supporting its safety.
Clotting drug tranexamic acid did not raise complication rates for high-risk patients undergoing orthopedic surgeries. (